Birdwatch Archive

Birdwatch Note

2024-05-03 02:58:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

イベルメクチンだけではがんは治りません。ヒトに対する臨床研究はまだ成功していません。 ファクトチェック済みのデマです。 https://factcheck.afp.com/doc.afp.com.33E87YP https://apnews.com/article/fact-check-ivermectin-nih-cancer-cure-629592291079 がんを患う人間に対して成功した結果をもたらした臨床試験の報告はありません。 根拠としてよく示される論文は、イベルメクチンががんの治療法であるとは示していません。論文は、その潜在的な用途についてさらなる臨床研究を求めています。 非常に高用量のイベルメクチンが実際に有毒である可能性があることもわかっています。 専門家らは、実際の治療に使用するには時期尚早だとし、医療当局はこの抗寄生虫薬を監督なしで服用しないよう警告しています。

Written by 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1785986449030123555

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1786228740646907998
  • noteId - 1786228740646907998
  • participantId -
  • noteAuthorParticipantId - 600FD0363C54FF998A92BA8063786EDEE94D51BFDDDA7E4B6EB475D435244AD2 Participant Details
  • createdAtMillis - 1714705092953
  • tweetId - 1785986449030123555
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • イベルメクチンだけではがんは治りません。ヒトに対する臨床研究はまだ成功していません。 ファクトチェック済みのデマです。 https://factcheck.afp.com/doc.afp.com.33E87YP https://apnews.com/article/fact-check-ivermectin-nih-cancer-cure-629592291079 がんを患う人間に対して成功した結果をもたらした臨床試験の報告はありません。 根拠としてよく示される論文は、イベルメクチンががんの治療法であるとは示していません。論文は、その潜在的な用途についてさらなる臨床研究を求めています。 非常に高用量のイベルメクチンが実際に有毒である可能性があることもわかっています。 専門家らは、実際の治療に使用するには時期尚早だとし、医療当局はこの抗寄生虫薬を監督なしで服用しないよう警告しています。

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-05-03 02:58:12 UTC
(1714705092953)
2024-05-03 10:45:26 UTC
(1714733126173)
CURRENTLY_RATED_HELPFUL 2024-05-04 06:16:06 UTC
(1714803366430)
CURRENTLY_RATED_HELPFUL 2024-05-03 10:45:26 UTC
(1714733126173)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-05-03 02:27:05 -0500 Rating Details
2024-05-03 00:44:44 -0500 Rating Details
2024-05-03 00:14:55 -0500 Rating Details
2024-05-03 00:10:51 -0500 Rating Details
2024-05-03 00:06:23 -0500 Rating Details
2024-05-02 23:45:33 -0500 Rating Details
2024-05-02 23:08:34 -0500 Rating Details
2024-05-02 23:02:57 -0500 Rating Details
2024-05-02 22:56:47 -0500 Rating Details
2024-05-02 22:51:33 -0500 Rating Details
2024-05-02 22:51:15 -0500 Rating Details
2024-05-02 22:48:52 -0500 Rating Details
2024-05-02 22:44:13 -0500 Rating Details
2024-05-02 22:42:02 -0500 Rating Details
2024-05-02 22:41:28 -0500 Rating Details
2024-05-02 22:36:41 -0500 Rating Details
2024-05-02 22:36:28 -0500 Rating Details
2024-05-02 22:33:16 -0500 Rating Details
2024-05-02 22:29:30 -0500 Rating Details
2024-05-02 22:27:02 -0500 Rating Details
2024-05-02 22:18:21 -0500 Rating Details
2024-05-02 22:14:04 -0500 Rating Details
2024-05-03 20:06:27 -0500 Rating Details
2024-05-03 20:04:13 -0500 Rating Details
2024-05-03 20:04:05 -0500 Rating Details
2024-05-03 17:32:04 -0500 Rating Details
2024-05-03 17:17:14 -0500 Rating Details
2024-05-03 13:22:48 -0500 Rating Details
2024-05-03 07:39:37 -0500 Rating Details
2024-05-03 04:42:58 -0500 Rating Details
2024-05-03 04:18:52 -0500 Rating Details
2024-05-03 03:37:50 -0500 Rating Details
2024-05-03 00:19:24 -0500 Rating Details
2024-05-03 00:03:19 -0500 Rating Details
2024-05-02 23:56:46 -0500 Rating Details
2024-05-02 23:42:10 -0500 Rating Details
2024-05-02 23:31:52 -0500 Rating Details
2024-05-02 23:02:50 -0500 Rating Details
2024-05-02 22:53:17 -0500 Rating Details
2024-05-02 22:48:22 -0500 Rating Details
2024-05-02 22:47:47 -0500 Rating Details
2024-05-02 22:45:39 -0500 Rating Details
2024-05-02 22:44:19 -0500 Rating Details
2024-05-02 22:43:19 -0500 Rating Details
2024-05-02 22:40:32 -0500 Rating Details
2024-05-02 22:39:24 -0500 Rating Details
2024-05-02 22:38:53 -0500 Rating Details
2024-05-02 22:37:48 -0500 Rating Details
2024-05-02 22:36:27 -0500 Rating Details
2024-05-02 22:36:03 -0500 Rating Details
2024-05-02 22:33:44 -0500 Rating Details
2024-05-02 22:31:09 -0500 Rating Details
2024-05-02 22:28:44 -0500 Rating Details
2024-05-02 22:25:02 -0500 Rating Details
2024-05-02 22:03:01 -0500 Rating Details
2024-05-05 03:20:16 -0500 Rating Details
2024-05-04 07:03:46 -0500 Rating Details
2024-05-04 02:33:29 -0500 Rating Details
2024-05-03 23:31:17 -0500 Rating Details
2024-05-03 20:23:28 -0500 Rating Details
2024-05-03 19:28:53 -0500 Rating Details
2024-05-03 17:47:06 -0500 Rating Details
2024-05-03 17:45:52 -0500 Rating Details
2024-05-03 16:18:55 -0500 Rating Details
2024-05-03 16:13:15 -0500 Rating Details
2024-05-03 14:02:09 -0500 Rating Details
2024-05-03 13:21:04 -0500 Rating Details
2024-05-03 13:20:35 -0500 Rating Details
2024-05-03 13:14:02 -0500 Rating Details
2024-05-03 08:13:23 -0500 Rating Details
2024-05-03 06:09:17 -0500 Rating Details
2024-05-03 05:04:42 -0500 Rating Details
2024-05-03 03:09:21 -0500 Rating Details
2024-05-03 02:22:50 -0500 Rating Details
2024-05-03 00:37:26 -0500 Rating Details
2024-05-02 23:14:36 -0500 Rating Details
2024-05-02 23:05:32 -0500 Rating Details
2024-05-02 22:56:32 -0500 Rating Details
2024-05-02 22:52:09 -0500 Rating Details
2024-05-02 22:46:27 -0500 Rating Details
2024-05-02 22:39:16 -0500 Rating Details
2024-05-02 22:36:54 -0500 Rating Details
2024-05-02 22:29:11 -0500 Rating Details
2024-05-02 22:22:43 -0500 Rating Details
2024-05-02 22:22:40 -0500 Rating Details
2024-05-02 22:18:52 -0500 Rating Details
2024-05-05 06:39:45 -0500 Rating Details
2024-05-05 03:46:16 -0500 Rating Details
2024-05-04 04:53:05 -0500 Rating Details
2024-05-04 03:07:28 -0500 Rating Details
2024-05-03 20:37:43 -0500 Rating Details
2024-05-03 18:42:17 -0500 Rating Details
2024-05-06 13:19:15 -0500 Rating Details
2024-05-05 08:57:55 -0500 Rating Details
2024-05-08 00:43:13 -0500 Rating Details
2024-05-05 17:36:04 -0500 Rating Details
2024-05-05 16:09:15 -0500 Rating Details
2024-05-05 06:32:33 -0500 Rating Details
2024-05-05 03:14:31 -0500 Rating Details
2024-05-04 12:55:29 -0500 Rating Details
2024-05-04 10:45:24 -0500 Rating Details
2024-05-04 05:05:21 -0500 Rating Details
2024-05-03 22:32:01 -0500 Rating Details
2024-05-03 21:06:32 -0500 Rating Details
2024-05-03 20:22:08 -0500 Rating Details
2024-05-03 19:47:59 -0500 Rating Details
2024-05-03 18:40:09 -0500 Rating Details
2024-05-03 16:23:54 -0500 Rating Details
2024-05-03 10:19:24 -0500 Rating Details
2024-05-03 07:48:07 -0500 Rating Details
2024-05-03 04:28:49 -0500 Rating Details
2024-05-05 03:56:02 -0500 Rating Details
2024-05-05 02:05:30 -0500 Rating Details
2024-05-05 01:54:28 -0500 Rating Details
2024-05-04 06:57:09 -0500 Rating Details
2024-05-04 00:23:52 -0500 Rating Details
2024-05-03 21:29:11 -0500 Rating Details
2024-05-03 19:12:26 -0500 Rating Details
2024-05-03 17:10:15 -0500 Rating Details
2024-05-03 14:43:33 -0500 Rating Details
2024-05-03 11:44:38 -0500 Rating Details
2024-05-03 09:59:48 -0500 Rating Details
2024-05-03 08:15:41 -0500 Rating Details
2024-05-03 07:08:41 -0500 Rating Details
2024-05-03 04:15:57 -0500 Rating Details
2024-05-03 03:19:53 -0500 Rating Details
2024-05-03 02:58:36 -0500 Rating Details
2024-05-03 02:23:29 -0500 Rating Details
2024-05-03 01:04:02 -0500 Rating Details
2024-05-03 00:13:03 -0500 Rating Details
2024-05-03 00:12:39 -0500 Rating Details
2024-05-02 23:59:24 -0500 Rating Details
2024-05-02 23:46:57 -0500 Rating Details
2024-05-02 23:44:55 -0500 Rating Details
2024-05-02 23:03:45 -0500 Rating Details
2024-05-02 22:26:27 -0500 Rating Details
2024-05-02 22:20:23 -0500 Rating Details
2024-05-02 22:13:52 -0500 Rating Details
2024-05-04 12:13:48 -0500 Rating Details
2024-05-03 05:07:14 -0500 Rating Details
2024-05-08 03:55:05 -0500 Rating Details
2024-05-04 00:40:45 -0500 Rating Details
2024-05-03 16:20:05 -0500 Rating Details
2024-05-03 13:23:08 -0500 Rating Details
2024-05-02 22:25:49 -0500 Rating Details
2024-05-05 03:02:06 -0500 Rating Details
2024-05-04 13:01:57 -0500 Rating Details
2024-05-08 07:28:08 -0500 Rating Details
2024-06-09 20:52:42 -0500 Rating Details